Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study

NCT00627133 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2018-06-07

No results posted yet for this study

Summary

Pilot study to evaluate efficacy of Keppra (levetiracetam) for seizure control in patients with alcohol related seizures.

Conditions

  • Seizure, Alcohol Related

Interventions

DRUG

levetiracetam

2 gram iv load, 500mg bid

Sponsors & Collaborators

  • UCB Pharma

    collaborator INDUSTRY
  • Medical University of South Carolina

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00627133 on ClinicalTrials.gov